Article Text

Download PDFPDF
Income, income inequality and schizophrenia in China: a population-based multilevel analysis
  1. Ruoxi Ding1,
  2. Lei Zhang1,
  3. Ping He2,
  4. Xinming Song1,
  5. Xiaoying Zheng1
  1. 1 Institute of Population Research, Peking University, Beijing, China
  2. 2 China Center for Health Development Studies, Peking University, Beijing, China
  1. Correspondence to Professor Xiaoying Zheng, Institute of Population Research, Peking University, Beijing 100871, China; xzheng{at}pku.edu.cn

Abstract

Background Previous studies have suggested that socio-environmental factors interact with genetic risk in the genesis of schizophrenia. This study aimed to investigate the relationship between income, income inequality and schizophrenia and its heterogeneity among different geographic scales and subgroups.

Methods We used data from the Second China National Sample Survey on Disability (2006). The sample consisted of 1 909 205 participants aged 18 years or older. Individuals who were suspected to be psychiatrically disabled were administered the WHO Disability Assessment Schedule, Version II and the International Statistical Classification of Diseases, Tenth Revision Symptom Checklist for Mental Disorders by trained clinical psychiatrists to diagnose schizophrenia. Gross household income per capita was used to calculate the Gini coefficient to measure income inequality. Multilevel logistic regression with cross-level interaction was applied to examine the association of income, income inequality and schizophrenia.

Results A total of 7 628 persons (0.40%) were identified as having schizophrenia. Income was independently associated with schizophrenia. At the province level, greater income inequality was significantly associated with a higher risk of schizophrenia (OR, 1.03; 95% CI 1.00 to 1.06), and no significant association was observed at the county level. The analysis with cross-level interaction showed that the association at the province level was most pronounced in the highest income quartile (OR, 1.02; 95% CI 1.00 to 1.03).

Conclusion The significant association between income and schizophrenia was consistent with the absolute income hypothesis. The adverse effect of income inequality on the risk of schizophrenia starts to operate at a larger area level, and it is more pronounced for the affluent population in China. This finding further supports the relative income hypothesis and social causation pathway for schizophrenia and calls attention to the vulnerability of high-income groups.

  • Disability
  • Environmental epidemiology
  • Epidemiology
  • Ageing
  • Child health
  • Education
  • Health impact assessment
  • Health services

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors R D initiated the study, analysed the data and wrote the original manuscript. P H and L Z provided advices on research design, data analysis and manuscript writing. X S provided advices on manuscript writing. X Z originated the study, obtained the funding, supervised all aspects of its implementation and contributed to writing the article. All authors contributed to and have approved the final manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Ethics approval This survey was approved by the China State Council (No. 20051104) and implemented within the legal framework governed by the Statistical Law of the People’s Republic of China (1996 Amendment), the Leading Group of the National Sample Survey on Disability and the National Bureau of Statistics conducted the survey. The informed consent was signed by all respondents for the participation and, if required, the clinical assessment process.

  • Data sharing statement Data may be obtained from a third party and are not publicly available.

  • Provenance and peer review Not commissioned; externally peer reviewed.